去年，Teva Pharmaceutical Industries Ltd表现最佳的业务板块Generic products实现营收9.42B美元。United States的营收贡献最高，去年达到9.19B美元。最近一个季度，截至2026-06-30，Teva Pharmaceutical Industries Ltd表现最佳的业务板块Generic products实现营收2.10B美元。United States的营收贡献最高，达到1.70B美元。

业务

营业收入

占比

年报

年报

单季报

Generic products

AUSTEDO

Other

Anda

AJOVY

COPAXONE

Respiratory products

UZEDY

BENDEKA / TREANDA

ProAir

QVAR

Distribution

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Generic products

9.42B(57.48%)

9.46B(60.65%)

8.73B(58.54%)

8.60B(61.97%)

8.99B(61.03%)

9.31B(60.66%)

9.33B(59.84%)

9.67B(55.30%)

11.04B(52.59%)

10.94B(52.68%)

AUSTEDO

2.26B(13.79%)

1.69B(10.82%)

1.24B(8.31%)

963.00M(6.94%)

802.00M(5.45%)

637.00M(4.15%)

412.00M(2.64%)

204.00M(1.17%)

24.00M(0.11%)

--(--)

Other

1.51B(9.19%)

1.38B(8.82%)

1.82B(12.19%)

1.19B(8.56%)

1.38B(9.34%)

1.25B(8.16%)

1.36B(8.70%)

1.68B(9.58%)

2.59B(12.34%)

2.97B(14.30%)

Anda

1.50B(9.13%)

1.54B(9.85%)

1.58B(10.57%)

1.47B(10.60%)

1.32B(8.98%)

1.46B(9.52%)

1.49B(9.57%)

1.35B(7.70%)

1.15B(5.49%)

301.00M(1.45%)

AJOVY

673.00M(4.11%)

507.00M(3.25%)

434.00M(2.91%)

377.00M(2.72%)

313.00M(2.13%)

165.00M(1.07%)

93.00M(0.60%)

--(--)

COPAXONE

468.00M(2.86%)

503.00M(3.22%)

591.00M(3.96%)

691.00M(4.98%)

1.00B(6.82%)

1.34B(8.71%)

1.51B(9.70%)

2.37B(13.53%)

3.80B(18.10%)

4.22B(20.34%)

Respiratory products

227.00M(1.38%)

244.00M(1.56%)

265.00M(1.78%)

273.00M(1.97%)

356.00M(2.42%)

353.00M(2.30%)

354.00M(2.27%)

402.00M(2.30%)

368.00M(1.75%)

239.00M(1.15%)

UZEDY

191.00M(1.17%)

117.00M(0.75%)

23.00M(0.15%)

--(--)

BENDEKA / TREANDA

147.00M(0.90%)

168.00M(1.08%)

237.00M(1.59%)

316.00M(2.28%)

385.00M(2.61%)

415.00M(2.70%)

496.00M(3.18%)

642.00M(3.67%)

656.00M(3.12%)

661.00M(3.18%)

ProAir

--(--)

180.00M(1.22%)

241.00M(1.57%)

274.00M(1.76%)

397.00M(2.27%)

501.00M(2.39%)

565.00M(2.72%)

QVAR

--(--)

179.00M(1.17%)

250.00M(1.60%)

182.00M(1.04%)

313.00M(1.49%)

409.00M(1.97%)

Distribution

--(--)

20.00M(0.13%)

602.00M(3.44%)

550.00M(2.62%)

458.00M(2.21%)

地区

营业收入

占比

年报

年报

单季报

United States

Europe

International Markets

Other

North America

North America.

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

9.19B(53.22%)

8.03B(48.56%)

7.73B(48.80%)

--(--)

Europe

5.04B(29.20%)

5.10B(30.84%)

4.84B(30.52%)

4.52B(30.31%)

4.89B(30.77%)

4.76B(28.55%)

4.79B(28.39%)

5.19B(27.51%)

5.47B(24.42%)

4.97B(14.81%)

4.89B(24.88%)

5.82B(28.72%)

5.99B(29.48%)

5.80B(28.54%)

5.80B(31.66%)

International Markets

2.16B(12.53%)

2.46B(14.89%)

2.35B(14.84%)

1.90B(12.75%)

2.03B(12.79%)

2.15B(12.93%)

2.25B(13.30%)

3.00B(15.94%)

3.40B(15.17%)

4.01B(11.97%)

3.51B(17.88%)

3.81B(18.82%)

3.87B(19.03%)

4.08B(20.09%)

3.71B(20.29%)

Other

870.00M(5.04%)

944.00M(5.71%)

926.00M(5.84%)

1.04B(7.00%)

1.15B(7.25%)

1.30B(7.82%)

1.30B(7.72%)

1.37B(7.25%)

1.38B(6.18%)

1.14B(3.40%)

--(--)

North America

--(--)

7.45B(49.94%)

7.81B(49.18%)

8.45B(50.71%)

8.54B(50.58%)

9.30B(49.31%)

12.14B(54.24%)

11.78B(35.10%)

--(--)

10.44B(51.38%)

8.80B(48.06%)

North America.

--(--)

11.65B(34.72%)

11.25B(57.24%)

10.63B(52.46%)

10.46B(51.50%)

--(--)